Suppr超能文献

[慢性心力衰竭不同细胞类型干细胞移植后心脏功能的变化]

[Changes of heart function after different cell type stem cell transplantation in chronic heart failure].

作者信息

Fan Zhongcai, Chen Mao, Deng Juelin, Liu Xiaojing, Zhang Li, Rao Li, Yang Qing, Huang Dejia

机构信息

Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006 Dec;23(6):1284-8.

Abstract

To investigate the feasibility of introcoronary cell infusion into nonischemic heart failure (HF) heart and whether different types of stem cell transplantation would affect heart function to a similar degree. Japanese white ears rabbits were used as HF models by intravenous injection adriamycin. Autologous bone marrow mononuclear cells(BMCs), bone marrow stromal cells (MSCs), skeletal myoblasts (SMs) or culture medium were infused into coronary arteries respectively by occluding the root of ascending aorta. The mortality during and 4 weeks after the procedure the mortality was 7.1% and 16.7% respectively. After 4 weeks, the ejection fraction (EF) in BMCs group had significant improvement (P < 0.05, n=8). No significant difference was seen in MSCs (n =8), SMs (n=6) and sham groups (n=8) compared with pretransplantation (P > 0.05). In sham group,the left ventricular endostolic diameter (LVED) had significant enlargement (P < 0.05), No significant difference was seen in MBCs, MSCs and SMs groups compared with pretransplantation (P > 0.05). Immunofluorescence revealed de novo expression of cardiac troponin I in BMCs and MSCs groups, cardiac troponin I was not detected in SMs group. In conclusions, intracoronary cell transplantation could provide effective cell delivery into dilated cardiomyopathy hearts and could be a useful strategy for treating CHF, BMCs cell transplantation may be the first choice in all the above cell types.

摘要

为研究冠状动脉内细胞输注至非缺血性心力衰竭(HF)心脏的可行性,以及不同类型的干细胞移植是否会对心脏功能产生相似程度的影响。采用静脉注射阿霉素的方法将日本白色耳兔作为HF模型。通过阻断升主动脉根部,分别将自体骨髓单个核细胞(BMCs)、骨髓基质细胞(MSCs)、骨骼肌成肌细胞(SMs)或培养基注入冠状动脉。手术期间及术后4周的死亡率分别为7.1%和16.7%。4周后,BMCs组的射血分数(EF)有显著改善(P<0.05,n=8)。与移植前相比,MSCs组(n =8)、SMs组(n=6)和假手术组(n=8)未见显著差异(P>0.05)。假手术组左心室舒张末期内径(LVED)有显著增大(P<0.05),与移植前相比,MBCs、MSCs和SMs组未见显著差异(P>0.05)。免疫荧光显示BMCs组和MSCs组有心肌肌钙蛋白I的新生表达,SMs组未检测到心肌肌钙蛋白I。结论:冠状动脉内细胞移植可为扩张型心肌病心脏提供有效的细胞递送,可能是治疗CHF的一种有用策略,BMCs细胞移植可能是上述所有细胞类型中的首选。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验